Improvements should be made cautiously as well as frequency of blood glucose monitoring should be amplified. Changes in concomitant oral antidiabetic treatment could be essential. Temporary SAFETY Assertion: Failure to utilize the Dexcom Continual Glucose Checking Program and its parts b